Complementary Medicine Research · 2020 · 24 citations · 23 references
MedicineEndocrinologyNutritional SciencesClinical NutritionHuman NutritionInflammationFunctional Gastrointestinal DisordersGastrointestinal InflammationIrritable Bowel SyndromeNutritional Modulation Of CytokinesVitamin DVitamin D DeficiencyControl Group DesignIbs-diarrhea PredominantIrritable Bowel Syndrome ComorbidityIrritable Bowel Syndrome PathophysiologyPlacebo-controlled Efficacy AssessmentRome CriteriaSymptom Score ImprovementVitamin D Insufficiency
OBJECTIVES: This study aimed to evaluate whether vitamin D deficiency is associated with the severity of symptoms of irritable bowel syndrome (IBS) patients. Stress and gut inflammation can increase the serum level of corticotropin-releasing hormone (CRH) and interleukin-6 (IL-6), leading to a change in bowel movements. The aim of this study was to evaluate the anti-inflammatory and psychological effects of vitamin D3 supplementation on the symptom improvement of patients with a diarrhea-predominant form of IBS (IBS-D). METHODS: Eighty-eight IBS-D patients (age: 18-65 years) based on Rome IV criteria who suffered from vitamin D deficiency and/or insufficiency were enrolled in this randomized, placebo-controlled trial from February 2017 to May 2018 at Rasoul-e-Akram Hospital, Tehran, Iran. Participants were randomly divided into two groups. The intervention group received 50,000 IU vitamin D3 weekly and the control group received a placebo for 9 weeks. All patients received Mebeverine 135 mg twice a day besides supplementation. The IBS Severity Score System (IBS-SSS), serum 25(OH) vitamin D3, CRH, and IL-6 were measured before and after interventions. RESULTS: Seventy-four patients completed the study. The severity of IBS symptoms (p < 0.01) and IL-6 (p = 0.02) decreased significantly in the intervention group as compared to the control group, but there was no significant difference in the serum level of CRH. Also, in the treatment group, IBS-SSS and IL-6 were significantly reduced at the end of the study from baseline (p < 0.01 and p < 0.03, respectively). CONCLUSION: Our findings indicate that vitamin D3 supplementation can modulate the serum level of CRH and IL-6 and can improve symptoms in IBS-D patients. Vitamin D3 supplementation should be considered in IBS-D patients who suffer from vitamin D deficiency and/or insufficiency.
23
Michael F. Holick, Neil Binkley, Heike A. Bischoff‐Ferrari et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 10.5K citations · Full text
Medicine, Endocrinology, Nutrition +17
Brian E. Lacy, Fermín Mearin, Lin Chang et al. · Gastroenterology · 2016 · 2.8K citations · Full text